Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, June 24 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on April 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

NOI - DNA/RNA Extraction Services from Multiple Tissue Types

Closed
75N98026Q00278Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

Department Of Health And Human Services → National Institutes Of Health Olao

NAICS

541380 - Testing Laboratories and ServicesView NAICS

Place of Performance

Beltsville, MD, USA

Set-Aside

NONE

Documents

(1)

75N98026Q00278+Combined+Synopsis+Solicitation-NONCOMPETITIVE.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Organization / Agency
Department Of Health And Human Services → National Institutes Of Health Olao
Office AddressBETHESDA, MD, 20892, USA
Contacts

Full Description

Show more

The National Institutes of Health (NIH), National Institute on Aging (NIA), intends to award a non-competitive purchase order to REPROCELL, Inc. for DNA and RNA extraction services from blood and multiple tissue types in support of an ongoing animal study. This requirement involves extraction and quality control analysis for approximately 320 DNA samples and 240 RNA samples derived from multiple organs. The proposed action is a continuation of previously performed work, and the use of the same vendor is necessary to ensure methodological consistency, minimize batch effects, and maintain comparability with existing datasets critical to the study’s scientific integrity. This acquisition is conducted under the authority of FAR 13.106-1(b)(1), as only one source is reasonably available to meet the Government’s requirement.